The Efficacy and Safety of FMX101, Minocycline Foam 4%, for the Treatment of Acne Vulgaris: A Pooled Analysis of Phase 2 and Phase 3 Studies
Abstract not available.Disclosures: Study supported by Foamix Pharmaceuticals, Inc.Copyright SKIN 2018
2014 ◽
Vol 24
(2)
◽
pp. 201-209
◽
Keyword(s):
2021 ◽
Vol 85
(3)
◽
pp. AB69
Keyword(s):